Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is looking at whether a digital support tool can help people with Schizophrenia. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
This study is looking at whether Dialectical Behavior Therapy Skills Training can help people with Psychosis or Suicide. Participants take part in Dialectical Behavior Therapy Skills Training and complete follow-up assessments.
This study is looking at care and outcomes for people with Schizophrenia and Related Disorders. Some participants may receive Sham rTMS stimulation instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at whether Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment can help people with Schizophrenia or Psychosis. Participants take part in Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment and complete follow-up assessments.
This study is looking at whether Motivational Interviewing can help people with Psychosis. Participants take part in the program and complete follow-up questionnaires or assessments.
This study is looking at care and outcomes for people with Schizophrenia. Some participants may receive Sham iTBS instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at whether a digital support tool can help people with Psychosis, Exergaming, or Elderly. Participants take part in a digital support tool and complete follow-up assessments.
This study is looking at whether treatment with ABCR helps patients with EPP reduce their alcohol and/or cannabis use for people with Psychosis, Alcohol Use Disorder, or Cannabis Use Disorder. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether Individualized imagery can help people with Psychosis. Participants take part in Individualized imagery and complete follow-up assessments.
This study is comparing Delta-9-THC Very Low Dose with placebo for people with Schizophrenia or Cannabis Use Disorder. Participants receive Delta-9-THC Very Low Dose or placebo and complete study visits and assessments.
This study is looking at whether a digital support tool can help people with Psychosis. Participants take part in a digital support tool and complete follow-up assessments.
This study is comparing VV119(SAD) with placebo for people with Schizophrenia. Participants receive VV119(SAD) or placebo and complete study visits and assessments.
This study is looking at whether Active rTMS can help people with Schizophrenia. Participants take part in Active rTMS and complete follow-up assessments.
This study is comparing Rivastigmine Transdermal System with placebo for people with Hallucinations, Auditory or Psychosis. Participants receive Rivastigmine Transdermal System or placebo and complete study visits and assessments.
This study is comparing High-intensity transcranial alternating current stimulation (Hi-tACS) with control group for people with Schizophrenia, Negative Type, or Transcranial Alternating Current Stimulation. Participants receive High-intensity transcranial alternating current stimulation (Hi-tACS) or control group and complete study visits and assessments.
This observational study is following people with Psychosis or Cannabis Use to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is comparing Ziprasidone with placebo for people with Schizophrenia. Participants receive Ziprasidone or placebo and complete study visits and assessments.
This study is looking at care and outcomes for people with Psychosis Associated With Alzheimer's Disease. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at care and outcomes for people with Psychosis Associated With Alzheimer's Disease. Taking part may give some people access to KarXT, but direct benefit is not guaranteed.
This study is looking at care and outcomes for people with Lewy Body Dementia Psychosis. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at care and outcomes for people with Psychosis Associated With Alzheimer's Disease. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is comparing MT1988 Low Dose with placebo for people with Clinical High Risk for Psychosis. Participants receive MT1988 Low Dose or placebo and complete study visits and assessments.
This observational study is following people with Alzheimer's Disease Psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This observational study is following people with Methamphetamine Use Disorder or Methamphetamine Induced Psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This observational study is following people with Methamphetamine Induced Psychosis to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.